OUR CAPABILITIES FOR BIOPHARMA PARTNERS
Veracyte offers its biopharma partners unique, multi-omic capabilities, expertise and tools designed to optimize biomarkers, companion diagnostics and therapeutic clinical trials through robust analysis of patient oncology samples. Our Immuno-oncology (IO) capabilities focus largely on the “immune contexture” of tumors (type, density, location and immune functions), which is strongly related to tumor progression and clinical outcome in patients. We utilize multiple technologies and proprietary artificial intelligence platforms and databases to help our biopharma partners advance precision medicine in the era of immuno-oncology and combination therapies.
FOR BIOPHARMA PARTNERS
Gain actionable insights to help accelerate the next generation of precision medicine in oncology with our multi-omic analysis of the tumor immune response, our unique Immunogram report and a comprehensive and proprietary cancer reference database made of genomic and immunomic biomarkers.
FOR IVD PARTNERS
Turn our experience into your success by partnering with Veracyte for any or all stages of your IVD development and manufacturing processes.